Epidemiological findings on interventional cardiology procedures during the COVID-19 pandemic: A multi-center study

Stefano Albani1, Hugo Vinhas2, Georgina Fuertes Ferre3

  • 1Division of Cardiology, Azienda Ospedaliera Ordine Mauriziano di Torino, Turin, Italy.

Indian Heart Journal
|October 10, 2021
PubMed

Insights

In-hospital mortality following percutaneous interventional procedures (PIP) rose significantly during the COVID-19 pandemic. This study highlights increased risks for patients undergoing cardiac interventions.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • The impact of the COVID-19 pandemic on in-hospital mortality after percutaneous interventional procedures (PIP) remains largely unquantified.
  • Previous studies have not systematically compared mortality rates during pandemic versus non-pandemic periods for PIP.

Purpose of the Study:

  • To investigate the changes in in-hospital mortality rates for patients undergoing PIP during the COVID-19 pandemic.
  • To compare these rates with those from a non-pandemic period.

Main Methods:

  • A retrospective analysis of consecutive patients undergoing PIP across five medical centers.
  • Data collection spanned from February 2020 to May 2020, encompassing the pandemic period.

Main Results:

  • A total of 4092 PIP were performed. The number of procedures decreased by 28.0% (from 2380 to 1712).
  • Overall in-hospital mortality increased from 1.1% in 2019 to 2.6% in 2020, representing a 63% relative increase.

Conclusions:

  • The COVID-19 pandemic was associated with a significant increase in in-hospital all-cause mortality for patients undergoing cardiological PIP.
  • These findings underscore potential increased risks and the need for careful management during public health crises.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
46
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
74
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
397
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
70
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
273
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
242